The Chicago-based company has been firing on all cylinders since the beginning of the year. Now, the company has beaten top and bottom-line estimates for 2Q23.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,